ArticleJournal of hematology & oncology2018

Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements.

C Roolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.